Bone augmentation of the atrophic posterior mandible for dental implants using rhBMP-2 and titanium mesh: Clinical technique and early results

International Journal of Periodontics and Restorative Dentistry

Volumn 31, Issue 6, 2011, Pages 581-589

  Misch, Craig M ^a,b  

^a New York University College of Dentistry ^*  (United States)

^b NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATROPHY; BONE DENSITY; BONE PROSTHESIS; BONE REGENERATION; BONE SCREW; CONE BEAM COMPUTED TOMOGRAPHY; FOLLOW UP; HUMAN; MANDIBLE; METHODOLOGY; ORAL SURGERY; OSTEOTOMY; PATHOLOGY; PHYSIOLOGY; PLASTIC SURGERY; SURGICAL EQUIPMENT; TOOTH CROWN; TOOTH IMPLANTATION; TOOTH PROSTHESIS; TOOTH RADIOGRAPHY; TREATMENT OUTCOME; WOUND HEALING;

ALVEOLAR RIDGE AUGMENTATION; ATROPHY; BIOCOMPATIBLE MATERIALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE SCREWS; BONE SUBSTITUTES; COLLAGEN; CONE-BEAM COMPUTED TOMOGRAPHY; CROWNS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; DRUG CARRIERS; FOLLOW-UP STUDIES; HUMANS; MANDIBLE; OSSEOINTEGRATION; OSTEOTOMY; RADIOGRAPHY, BITEWING; RECOMBINANT PROTEINS; SURGICAL FLAPS; SURGICAL MESH; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; WOUND HEALING;

EID: 84861111656     PISSN: 01987569     EISSN: 19453388     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Grant BT, Pancko FX, Kraut RA. Outcomes of placing short dental implants in the posterior mandible: A retrospective study of 124 cases. J Oral Maxillofac Surg 2009; 67: 713-717.
2. Peleg M, Mazor Z, Chaushu G, Garg AK. Lateralization of the inferior alveolar nerve with simultaneous implant placement: A modified technique. Int J Oral Maxillofac Implants 2002; 17: 101-106.
3. Cordaro L, Amadé DS, Cordaro M. Clinical results of alveolar ridge augmentation with mandibular block bone grafts in partially edentulous patients prior to implant placement. Clin Oral Implants Res 2002; 13: 103-111.
4. Garcia-Garcia A, Somoza-Martin M, Gandara-Vila P, Saulacic N, Gandara-Rey JM. Alveolar distraction before insertion of dental implants in the posterior mandible. Br J Oral Maxillofac Surg 2003; 41: 376-379.
5. Simion M, Jovanovic SA, Tinti C, Benfenati SP. Long-term evaluation of osseointegrated implants inserted at the time or after vertical ridge augmentatio. A retrospective study on 123 implants with 1-5 year follow-up. Clin Oral Implants Res 2001; 12: 35-45.
6. Louis PJ, Gutta R, Said-Al-Naief N, Bartolucci AA. Reconstruction of the maxilla and mandible with particulate bone graft and titanium mesh for implant placement. J Oral Maxillofac Surg 2008; 66: 235-245.
7. Jensen OT. Alveolar segmental "sandwich" osteotomies for posterior edentulous mandibular sites for dental implants. J Oral Maxillofac Surg 2006; 64: 471-475.
8. Misch CM. Immediate loading of definitive implants in the edentulous mandible using a fixed provisional prosthesis: The denture conversion technique. J Oral Maxillofac Surg 2004; 62(suppl 2): 106-115.
9. Misch CE. Root form surgery. In: Contemporary Implant Dentistry. Misch CE (ed). St Louis: Mosby, 1999: 360.
10. Boyne P. Osseous Reconstruction of the Maxilla and the Mandible: Surgical Techniques Using Titanium Mesh and Bone Mineral. Chicago: Quintessence, 1997: 1-100.
11. Proussaefs P, Lozada J, Kleinman A, Rohrer MD, McMillan PJ. The use of titanium mesh in conjunction with autogenous bone graft and inorganic bovine bone mineral (Bio-Oss) for localized alveolar ridge augmentation: A human study. Int J Periodontics Restorative Dent 2003; 23: 185-195.
12. Fiorellini JP, Howell TH, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005; 76: 605-613.
13. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005; 63: 1693-1707.
14. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008; 66: 616-624.
15. Fallucco MA, Carstens MH. Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: Clinical and radiographic outcomes. J Craniofac Surg 2009; 20(suppl 2): 1759-1764.
16. Misch CE. Density of bone: Effect on treatment plans, surgical approach, healing, and progressive bone loading. Int J Oral Implantol 1990; 6: 23-31.
17. McKay WF, Peckham SM, Marotta JS. Preclinical efficacy of rhBMP-2 and ACS. In: McKay WF, Peckham SM, Marotta JS. The Science of rhBMP-2. St Louis: Quality Medical Publishing, 2006: 88-116.
18. Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg 1988; 81: 672-676.
19. Jovanovic SA, Hunt DR, Bernard GW, Spiekermann H, Wozney JM, Wikesjö UM. Bone reconstruction following implantation of rhBMP-2 and guided bone regeneration in canine alveolar ridge defects. Clin Oral Implants Res 2007; 18: 224-230.
20. Wozney JM, Wikesjo UME. rhBMP-2: Biology and applications in oral and maxillofacial surgery and periodontics. In: Tissue Engineering, ed 2. Lynch SE, Marx RE, Nevins M, Wisner-Lynch LA (eds). Chicago: Quintessence, 2008: 159-177.
21. Schopper C, Moser D, Spassova E, et al. Bone regeneration using a naturally grown HA/TCP carrier loaded with rh-BMP-2 is independent of barrier-membrane effects. J Biomed Mater Res A 2008; 85: 954-963.
22. Gutta R, Baker RA, Bartolucci AA, Louis PJ. Barrier membranes used for ridge augmentation: Is there an optimal pore size? J Oral Maxilofac Surg 2009; 67: 1218-1225.
23. Wikesjö UM, Qahash M, Thomson RC, et al. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 2003; 5: 112-123.
24. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC. Comparison of Healos/bone marrow to INFUSE (rhBMP-2/ACS) with a collagenceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 2005; 30: 1001-1007.
25. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84: 2123-2134.
26. Li G, Cui Y, McIlmurray L, Allen WE, Wang H. rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 2005; 23: 680-685.
27. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143: 1545-1553.